

Wondering why Cefprozil is so hard to find in 2026? Learn the real reasons behind supply issues and what you can do to fill your prescription today.
You just left the doctor's office with a prescription for Cefprozil — an antibiotic you need to treat an ear infection, sinus infection, or bronchitis. You drive to the pharmacy, drop off your script, and hear those dreaded words: "We don't have it in stock."
If this sounds familiar, you're not alone. Patients across the country have been struggling to find Cefprozil at their local pharmacies, and the frustration is real. In this article, we'll explain exactly what's going on with Cefprozil supply in 2026, why it's become harder to find, and — most importantly — what you can do about it.
Cefprozil (formerly sold under the brand name Cefzil) is a second-generation cephalosporin antibiotic. It's prescribed to treat a variety of common bacterial infections, including:
Cefprozil works by stopping bacteria from building their cell walls, which kills the bacteria and clears up your infection. It comes in tablet form (250 mg and 500 mg) and as a liquid suspension, making it a popular choice for both adults and children.
The brand-name version, Cefzil, has been discontinued, but Cefprozil is widely available as a generic medication — at least, it's supposed to be.
There are several reasons why you might be having trouble finding Cefprozil at your pharmacy. Let's break down the most common ones.
Since the brand-name Cefzil was discontinued by Bristol-Myers Squibb, only a handful of generic manufacturers produce Cefprozil. When you have fewer companies making a drug, any disruption at even one facility can cause ripple effects across the entire supply chain. Currently, manufacturers like Lupin, Sandoz, Aurobindo, and Teva produce generic Cefprozil, but production levels don't always keep up with demand.
The pharmaceutical supply chain is global, and Cefprozil is no exception. Active pharmaceutical ingredients (APIs) for cephalosporin antibiotics are often manufactured overseas. Disruptions in raw material supply, shipping delays, or quality control issues at API manufacturing plants can all slow down production and limit what's available on pharmacy shelves.
Cefprozil is commonly prescribed for ear infections, sinus infections, and bronchitis — infections that tend to spike during cold and flu season (roughly October through March). During these months, demand for oral antibiotics surges, and pharmacies may run out faster than their distributors can restock.
Not every pharmacy stocks every medication. Large chain pharmacies tend to carry the most commonly prescribed antibiotics, and Cefprozil — while well-known — isn't always the first-choice antibiotic for every condition. Some pharmacies may stock limited quantities or may not carry it at all, especially in areas where prescribers tend to favor other antibiotics like Amoxicillin or Cefdinir.
The good news is that there are real, practical steps you can take to fill your prescription. Here's what we recommend:
Medfinder helps you search for pharmacies that actually have Cefprozil in stock right now. Instead of calling pharmacy after pharmacy, you can check availability in your area with just a few clicks. It's free and designed specifically for situations like this.
Large chain pharmacies aren't your only option. Independent pharmacies often have different supply relationships with wholesalers and may have medications in stock when the big chains don't. Compounding pharmacies may also be able to prepare Cefprozil suspension if the commercially manufactured version is unavailable.
If you've tried multiple pharmacies and still can't find Cefprozil, talk to your prescriber. There are several effective alternatives in the same drug class, including:
Your doctor can determine which alternative is best based on your specific infection and medical history.
Save yourself time and frustration by calling pharmacies before you go. Ask them directly if they have Cefprozil in the strength and form your prescription calls for. If they don't, ask when they expect their next shipment.
If your infection is not urgent and your doctor agrees, a mail-order pharmacy may have better access to Cefprozil through their larger distribution networks. Many insurance plans offer mail-order pharmacy benefits that can also save you money. Check out our guide on how to save money on Cefprozil for more tips.
As of early 2026, Cefprozil is not officially listed on the FDA's drug shortage database. However, that doesn't mean patients aren't experiencing difficulty finding it. Spot shortages — where certain pharmacies or regions run out temporarily — can happen without an official national shortage being declared.
The oral suspension form of Cefprozil has been particularly affected by intermittent supply disruptions in recent years, partly because fewer manufacturers produce the liquid form compared to tablets. If your prescription is for the suspension (often prescribed for children), you may face more difficulty.
For the latest information, read our Cefprozil shortage update for 2026.
Finding Cefprozil in 2026 can be challenging, but it's not impossible. Limited manufacturers, supply chain disruptions, and seasonal demand all play a role in making this antibiotic harder to locate. The key is to be proactive: use tools like Medfinder to check availability, explore independent pharmacies, and talk to your doctor about alternatives if needed.
You shouldn't have to put your health on hold because of a supply issue. With the right approach, you can get the treatment you need.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.